Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - TSX:ACO-X - CA0467894006 - Common Stock

55.93 CAD
-0.94 (-1.65%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

5

Overall ACO-X gets a fundamental rating of 5 out of 10. We evaluated ACO-X against 21 industry peers in the Multi-Utilities industry. ACO-X has an average financial health and profitability rating. ACO-X has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ACO-X had positive earnings in the past year.
In the past year ACO-X had a positive cash flow from operations.
ACO-X had positive earnings in each of the past 5 years.
In the past 5 years ACO-X always reported a positive cash flow from operatings.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

ACO-X's Return On Assets of 1.64% is in line compared to the rest of the industry. ACO-X outperforms 47.62% of its industry peers.
ACO-X has a Return On Equity of 9.28%. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
The Return On Invested Capital of ACO-X (3.71%) is better than 71.43% of its industry peers.
ACO-X had an Average Return On Invested Capital over the past 3 years of 3.92%. This is in line with the industry average of 3.65%.
Industry RankSector Rank
ROA 1.64%
ROE 9.28%
ROIC 3.71%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ACO-X has a Profit Margin (8.65%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ACO-X has declined.
ACO-X has a worse Operating Margin (24.24%) than 71.43% of its industry peers.
ACO-X's Operating Margin has declined in the last couple of years.
ACO-X has a Gross Margin of 75.61%. This is comparable to the rest of the industry: ACO-X outperforms 47.62% of its industry peers.
ACO-X's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.24%
PM (TTM) 8.65%
GM 75.61%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

ACO-X has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ACO-X remains at a similar level compared to 1 year ago.
ACO-X has less shares outstanding than it did 5 years ago.
ACO-X has a worse debt/assets ratio than last year.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

ACO-X has an Altman-Z score of 0.78. This is a bad value and indicates that ACO-X is not financially healthy and even has some risk of bankruptcy.
ACO-X's Altman-Z score of 0.78 is amongst the best of the industry. ACO-X outperforms 80.95% of its industry peers.
The Debt to FCF ratio of ACO-X is 33.61, which is on the high side as it means it would take ACO-X, 33.61 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACO-X (33.61) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 2.56 is on the high side and indicates that ACO-X has dependencies on debt financing.
ACO-X has a Debt to Equity ratio of 2.56. This is in the lower half of the industry: ACO-X underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF 33.61
Altman-Z 0.78
ROIC/WACC0.73
WACC5.1%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

ACO-X has a Current Ratio of 1.61. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X has a Current ratio of 1.61. This is amongst the best in the industry. ACO-X outperforms 100.00% of its industry peers.
ACO-X has a Quick Ratio of 1.45. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X has a better Quick ratio (1.45) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.45
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.20% over the past year.
The Earnings Per Share has been growing slightly by 6.10% on average over the past years.
The Revenue has been growing slightly by 7.64% in the past year.
ACO-X shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.98% yearly.
EPS 1Y (TTM)10.2%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%3.49%
Revenue 1Y (TTM)7.64%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%4.14%

3.2 Future

The Earnings Per Share is expected to grow by 4.92% on average over the next years.
The Revenue is expected to grow by 0.61% on average over the next years.
EPS Next Y8.28%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
EPS Next 5YN/A
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.63, the valuation of ACO-X can be described as correct.
ACO-X's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.89, ACO-X is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 12.01, the valuation of ACO-X can be described as correct.
Based on the Price/Forward Earnings ratio, ACO-X is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
ACO-X is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.63
Fwd PE 12.01
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACO-X indicates a somewhat cheap valuation: ACO-X is cheaper than 76.19% of the companies listed in the same industry.
ACO-X's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.27
EV/EBITDA 8.35
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.52
PEG (5Y)2.07
EPS Next 2Y4.17%
EPS Next 3Y4.92%

6

5. Dividend

5.1 Amount

ACO-X has a Yearly Dividend Yield of 3.77%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.94, ACO-X's dividend is way lower than its industry peers. On top of this 95.24% of the companies listed in the same industry pay a better dividend than ACO-X!
ACO-X's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 3.77%

5.2 History

The dividend of ACO-X has a limited annual growth rate of 3.93%.
ACO-X has been paying a dividend for at least 10 years, so it has a reliable track record.
ACO-X has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACO-X pays out 50.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACO-X is growing, but earnings are growing more, so the dividend growth is sustainable.
DP50.8%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (11/14/2025, 7:00:00 PM)

55.93

-0.94 (-1.65%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07
Earnings (Next)02-25 2026-02-25
Inst Owners29.15%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap6.27B
Revenue(TTM)5.08B
Net Income(TTM)439.00M
Analysts78.57
Price Target57.41 (2.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.77%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP50.8%
Div Incr Years31
Div Non Decr Years34
Ex-Date12-04 2025-12-04 (0.5045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)1.49%
EPS beat(4)3
Avg EPS beat(4)2.9%
Min EPS beat(4)-3.78%
Max EPS beat(4)10.76%
EPS beat(8)7
Avg EPS beat(8)4.49%
EPS beat(12)9
Avg EPS beat(12)3.59%
EPS beat(16)12
Avg EPS beat(16)4.35%
Revenue beat(2)0
Avg Revenue beat(2)-9.2%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-0.7%
Revenue beat(4)0
Avg Revenue beat(4)-10.59%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-12.35%
Revenue beat(12)1
Avg Revenue beat(12)-9.18%
Revenue beat(16)2
Avg Revenue beat(16)-8.91%
PT rev (1m)0.51%
PT rev (3m)1.03%
EPS NQ rev (1m)1.12%
EPS NQ rev (3m)1.12%
EPS NY rev (1m)0.71%
EPS NY rev (3m)4.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.42%
Revenue NY rev (3m)-4.54%
Valuation
Industry RankSector Rank
PE 12.63
Fwd PE 12.01
P/S 1.24
P/FCF 17.27
P/OCF 2.67
P/B 1.33
P/tB 1.85
EV/EBITDA 8.35
EPS(TTM)4.43
EY7.92%
EPS(NY)4.66
Fwd EY8.32%
FCF(TTM)3.24
FCFY5.79%
OCF(TTM)20.96
OCFY37.47%
SpS45.28
BVpS42.2
TBVpS30.23
PEG (NY)1.52
PEG (5Y)2.07
Graham Number64.85
Profitability
Industry RankSector Rank
ROA 1.64%
ROE 9.28%
ROCE 4.79%
ROIC 3.71%
ROICexc 3.82%
ROICexgc 4.03%
OM 24.24%
PM (TTM) 8.65%
GM 75.61%
FCFM 7.15%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF 33.61
Debt/EBITDA 5.88
Cap/Depr 238.99%
Cap/Sales 39.13%
Interest Coverage 2.29
Cash Conversion 113.97%
Profit Quality 82.69%
Current Ratio 1.61
Quick Ratio 1.45
Altman-Z 0.78
F-Score6
WACC5.1%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.2%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%3.49%
EPS Next Y8.28%
EPS Next 2Y4.17%
EPS Next 3Y4.92%
EPS Next 5YN/A
Revenue 1Y (TTM)7.64%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%4.14%
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A
EBIT growth 1Y15.06%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year427.2%
EBIT Next 3Y80.42%
EBIT Next 5YN/A
FCF growth 1Y-5.22%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y13.97%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ACO-X.CA.


Can you provide the valuation status for ATCO LTD -CLASS I?

ChartMill assigns a valuation rating of 4 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


How profitable is ATCO LTD -CLASS I (ACO-X.CA) stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 5 / 10.


What is the valuation of ATCO LTD -CLASS I based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ATCO LTD -CLASS I (ACO-X.CA) is 12.63 and the Price/Book (PB) ratio is 1.33.


How financially healthy is ATCO LTD -CLASS I?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.